These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26062065)

  • 1. II. Challenges in the management of post-transplant lymphoproliferative disorder.
    Nassi L; Gaidano G
    Hematol Oncol; 2015 Jun; 33 Suppl 1():96-9. PubMed ID: 26062065
    [No Abstract]   [Full Text] [Related]  

  • 2. [The importance of more research on post-transplant lymphoproliferative disorders in China].
    Liu QF
    Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):977-8. PubMed ID: 18478909
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-transplant lymphoproliferative disorder.
    Loren AW; Tsai DE
    Clin Chest Med; 2005 Dec; 26(4):631-45, vii. PubMed ID: 16263402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders.
    Komrokji RS; Oliva JL; Zand M; Felgar R; Abboud CN
    Am J Hematol; 2005 Jul; 79(3):211-5. PubMed ID: 15981226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with the trifunctional anti-CD20 × anti-CD3 antibody FBTA05 in a patient with relapsed t(8;14)-positive post-transplant lymphoproliferative disease.
    Kieslich A; Ruf P; Lindhofer H; Buhmann R; Eggert A; Hundsdoerfer P
    Leuk Lymphoma; 2017 Aug; 58(8):1989-1992. PubMed ID: 28093004
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines.
    Parker A; Bowles K; Bradley JA; Emery V; Featherstone C; Gupte G; Marcus R; Parameshwar J; Ramsay A; Newstead C;
    Br J Haematol; 2010 Jun; 149(5):693-705. PubMed ID: 20408848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.
    Svoboda J; Kotloff R; Tsai DE
    Transpl Int; 2006 Apr; 19(4):259-69. PubMed ID: 16573540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiology, diagnosis, and treatment of post-transplant lymphoproliferative disorders].
    Zhu P
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2957-8. PubMed ID: 17288804
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary post-transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients.
    Taj MM; Maecker-Kolhoff B; Ling R; Bomken S; Burkhardt B; Chiang AKS; Csoka M; Füreder A; Haouy S; Lazic J; Miakova N; Minard-Colin V; Turner SD; Uyttebroeck A; Attarbaschi A;
    Br J Haematol; 2021 Jun; 193(6):1178-1184. PubMed ID: 33764500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disorders.
    Singavi AK; Harrington AM; Fenske TS
    Cancer Treat Res; 2015; 165():305-27. PubMed ID: 25655616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Latest update on immunotherapy of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease].
    Hao QF; Sheng GY; Luan Z
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):795-9. PubMed ID: 24034931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of patients with lymphoproliferative disorders after allogeneic hematopoietic stem cell transplant].
    Gu B; Chen GH; Wang Y
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1046-9. PubMed ID: 23363801
    [No Abstract]   [Full Text] [Related]  

  • 13. Late-onset post-transplant lymphoproliferative disease: a report of four patients in one center.
    Ramadan KM; Bowers M; El-Agnaf MR; Kettle P
    Leuk Lymphoma; 2006 Jun; 47(6):1191-3. PubMed ID: 16840223
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease.
    González-Barca E; Domingo-Domenech E; Capote FJ; Gómez-Codina J; Salar A; Bailen A; Ribera JM; López A; Briones J; Muñoz A; Encuentra M; de Sevilla AF; ; ;
    Haematologica; 2007 Nov; 92(11):1489-94. PubMed ID: 18024397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.
    Yoon JH; Lee S; Kim HJ; Lee JW; Min WS; Chung BH; Yang CW; Kim YS; Kim JI; Moon IS; Oh EJ; Park GS; Cho SG
    Transpl Int; 2014 Jul; 27(7):721-32. PubMed ID: 24684689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Post transplant lymphoprolipherative disorder (PTLD) in patients after kidney transplantation--clinical manifestation, treatment and prognosis].
    Pałka K; Ignacak E; Sułowicz W
    Przegl Lek; 2012; 69(9):675-9. PubMed ID: 23401988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of post-transplant lymphomas.
    Coiffier B
    Oncology (Williston Park); 2010 Sep; 24(10):950-1. PubMed ID: 21138177
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum immunoglobulin free light chains and post-transplant lymphoproliferative disorder among allogeneic hematopoietic stem cell transplant recipients.
    Engels EA; Landgren O; Costello R; Burton D; Mailankody S; Storek J
    Bone Marrow Transplant; 2015 Jan; 50(1):146-7. PubMed ID: 25265459
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of immunosuppression in post-transplant lymphoproliferative disorders treated with CAR T cells.
    Jimkap N; El Baroudi O; Lemoine J; Pievani D; Pastoret C; Houot R
    Br J Haematol; 2024 May; 204(5):2112-2116. PubMed ID: 38411293
    [No Abstract]   [Full Text] [Related]  

  • 20. Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute.
    Hou HA; Yao M; Tang JL; Chen YK; Ko BS; Huang SY; Tien HF; Chang HH; Lu MY; Lin TT; Lin KH; Hsiao CH; Lin CW; Chen YC
    Bone Marrow Transplant; 2009 Feb; 43(4):315-21. PubMed ID: 18836488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.